Position in LEGN
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$5,776
+$2,158 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#198
of 218 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Harvest Fund Management Co., Ltd holds $18,814,641 across 10 Biotechnology names. LEGN ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,560 | $9,716,038 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,900 | $4,925,966 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,981 | $3,004,580 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
7,432 | $581,702 | |
| 5 | EXEL |
Exelixis, Inc.
|
7,699 | $418,902 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
892 | $66,436 | |
| 7 | BNTX |
BioNTech SE
|
600 | $55,830 | |
| 8 | INCY |
Incyte Corp
|
184 | $20,858 |
All Filings in LEGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,776 | 200 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $3,618 | 200 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,348 | 200 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $104,352 | 3,200 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||